This bill amends Section 37-2711 of the Idaho Code to classify the drugs Mifepristone and Misoprostol as Schedule IV controlled substances. The inclusion of these drugs in this schedule indicates that they are recognized as having a lower potential for abuse compared to substances in higher schedules, while still being regulated. The bill also removes Pentazocine from the list of substances in this section, indicating a shift in the regulatory focus.

Additionally, the bill declares an emergency, allowing it to take effect on July 1, 2025. This expedited timeline suggests a sense of urgency regarding the regulation of these specific drugs, likely in response to public health considerations or legislative priorities surrounding reproductive health and medication access.

Statutes affected:
Bill Text: 37-2711